thiazolyl blue has been researched along with rasagiline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, T; Bar-Am, O; Youdim, MB | 1 |
| Johnson, C; Johnson, S; Lu, D; Ou, XM; Stockmeier, CA; Tazik, S; Youdim, MB | 1 |
2 other study(ies) available for thiazolyl blue and rasagiline
| Article | Year |
|---|---|
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro.
Topics: Animals; Apoptosis; bcl-X Protein; Blotting, Western; Cell Line; Cell Survival; Humans; Indans; Neurons; Neuroprotective Agents; Oxidopamine; PC12 Cells; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Rats; Sympatholytics; Tetrazolium Salts; Thiazoles | 2007 |
Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Apoptosis; Brain; Cell Line, Tumor; Dexamethasone; Dose-Response Relationship, Drug; Glioblastoma; Humans; In Situ Nick-End Labeling; Indans; Monoamine Oxidase; Neuroblastoma; Neuroprotective Agents; Selegiline; Tetrazolium Salts; Thiazoles | 2009 |